Prognostic value of <scp>PD</scp>‐L1 expression in combination with <scp>CD</scp>8<sup>+</sup><scp>TIL</scp>s density in patients with surgically resected non‐small cell lung cancer

Hui Yang(Nanjing University of Chinese Medicine), Caicun Zhou(Tongji University)

Cancer Medicine

November 23, 2017

10.1002/cam4.1243

Cited by 49

Related Papers

Iconographies supplémentaires de l'article : Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

|Unknown|2011|5